Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice-Reference-Cited by-同舟云学术

Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice

Published:2019-04 Issue: Volume:137 Page:56-67
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Luan Xue,Rahme Kamil,Cong Zhongcheng,Wang Limei,Zou Yifang,He Yan,Yang Hao,Holmes Justin D.,O'Driscoll Caitriona M.,Guo Jianfeng

Funder

Outstanding Youth Foundation from the Department of Science and Technology, Jilin Province, China

Start-Up Research Grant Program from Jilin University

Fundamental Research Funds for the Central Universities, China

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference78 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. The role of transcription factors in prostate cancer and potential for future RNA interference therapy;Fitzgerald;Expert Opin. Ther. Targets,2014

3. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells;Elbashir;Nature,2001

4. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?;Guo;Biotechnol. Adv.,2011

5. Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities;Wang;Biotechnol. Adv.,2014

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in non-viral nanoparticle-based gene therapy for effective management of cancer;Journal of Drug Delivery Science and Technology;2024-10

2. cGAS-STING activation by nanodelivery of teniposide achieves colorectal cancer chemo-immunotherapy;European Polymer Journal;2024-10

3. Advancements in nanoengineered paclitaxel formulations: A comprehensive review of blood-brain barrier infiltration strategies for glioblastoma therapy;Biomedical Engineering Advances;2024-06

4. Nano delivery of juglone causes cell cycle arrest and apoptosis for hepatocellular carcinoma therapy;Journal of Drug Delivery Science and Technology;2024-03

5. Nanomedicine-RNAi interface: Architypes in prostate cancer therapeutics;Journal of Drug Delivery Science and Technology;2024-02